Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

Cardiovascular and metabolic disorders, such as hypertension, insulin resistance, dyslipidemia or obesity are linked with chronic low-grade inflammation and dysregulation of the renin–angiotensin system (RAS). Consequently, RAS inhibition by ACE inhibitors or angiotensin AT1 receptor (AT1R) blockers...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulis, Ludovit, Foulquier, Sébastien, Namsolleck, Pawel, Recarti, Chiara, Steckelings, Ulrike Muscha, Unger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700059/
https://www.ncbi.nlm.nih.gov/pubmed/26631237
http://dx.doi.org/10.1007/s40265-015-0509-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700059/
https://www.ncbi.nlm.nih.gov/pubmed/26631237
http://dx.doi.org/10.1007/s40265-015-0509-4

Ejemplares similares